Application of Classic Utilities to Published Pediatric Cost-Utility Studies

被引:10
|
作者
Finnell, S. Maria E. [1 ,3 ]
Carroll, Aaron E. [1 ,2 ,3 ]
Downs, Stephen M. [1 ,2 ,3 ]
机构
[1] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[2] Ctr Hlth Policy & Professionalism Res, Indianapolis, IN USA
[3] Regenstrief Inst Healthcare, Indianapolis, IN USA
关键词
cost effectiveness; cost-utility analysis; quality-adjusted life years; utility; child; cost benefit analysis; INTRATHECAL BACLOFEN THERAPY; QUALITY-OF-LIFE; ROTAVIRUS VACCINATION; CHILDHOOD IMMUNIZATION; THRESHOLD RETINOPATHY; INFANT VACCINATION; CHILDREN; HEALTH; IMPACT; CARE;
D O I
10.1016/j.acap.2011.09.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: Economic analyses, such as cost-utility analyses (CUAs), are dependent on the quality of the data used. Our objective was to test how health utility values (measurements of patient preference) assessed by recommended methods (classic utilities) would impact the conclusions in published pediatric CUAs. METHODS: Classic utilities for pediatric health states were obtained by recommended utility assessment methods, time trade-off, and standard gamble in 4016 parent interviews. To test the impact of these utilities on published studies, we obtained a sample of published pediatric CUAs by searching Medline, EMBASE, EconLit, Health Technology Assessment Database, Cochrane Database on Systematic Reviews, Database of Abstracts of Reviews of Effects, and the Cost Effective Analysis (CEA) Registry at Tufts Medical Center, using search terms for cost-utility analysis. Articles were included when results were presented as cost per quality adjusted life-years (QALYs), the interventions were for children <18 years of age and included at least one of the following health states: attention deficit hyperactivity disorder, asthma, gastroenteritis, hearing loss, mental retardation, otitis media, seizure disorder, or vision loss. Studies that did not include these or equivalent health states were excluded. For each CUA, we determined utilities (values for patient preference), the utility assessment method used, and presence of one-way sensitivity analyses (SAs) on utilities. When one-way SAs were conducted, we determined if using our classic utilities would change the result of the CUA. When an SA was not presented, we determined if using our classic utilities would tend to support or not support the published conclusions. RESULTS: We evaluated 39 articles. Eighteen articles presented results of one-way SAs on utilities. Seven articles presented SAs over a range that included our classic utilities. In 4 of the 7, using classic utilities would change the conclusion of the study. For the 32 articles where no one-way SA were presented (n = 21), or where the classic utilities fell outside the range tested (n =11), a change to classic utility would tend against the study conclusion in 12 articles (31%). CONCLUSIONS: More than a third of published CUA studies could change if pediatric utilities obtained by recommended, classic methods were used. One-way SAs on utilities are often not presented, making comparison between studies challenging.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [21] Reporting of key data in abstracts of published cost-utility analyses.
    Rosen, AB
    Olchanski, NV
    Greenberg, D
    Chapman, RH
    Neumann, P
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 165 - 165
  • [22] Diffusion of published cost-utility analyses in the field of health policy and practice
    Sonnad, SS
    Greenberg, D
    Rosen, AB
    Neumann, PJ
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (03) : 399 - 402
  • [23] The quality of reporting in published cost-utility analyses, 1976-1997
    Neumann, PJ
    Stone, PW
    Chapman, RH
    Sandberg, EA
    Bell, CM
    ANNALS OF INTERNAL MEDICINE, 2000, 132 (12) : 964 - 972
  • [24] Health state utilities associated with hyperphagia: Data for use in cost-utility models
    Howell, Timothy A.
    Matza, Louis S.
    Mallya, Usha G.
    Goldstone, Anthony P.
    Butsch, W. Scott
    Lazarus, Ethan
    OBESITY SCIENCE & PRACTICE, 2023, 9 (04): : 376 - 382
  • [25] EVALUATING THE QUALITY OF HEALTH-STATE UTILITIES IN COST-UTILITY ANALYSES IN ASIA
    Yang, Z.
    Zeng, X.
    Huang, W.
    Chuang, L. H.
    Luo, N.
    VALUE IN HEALTH, 2022, 25 (01) : S224 - S224
  • [26] Quality-adjusted life-years lack quality in pediatric care: A critical review of published cost-utility studies in child health
    Griebsch, I
    Coast, J
    Brown, J
    PEDIATRICS, 2005, 115 (05) : E600 - E614
  • [27] QALYs lack quality in paediatric care: A critical review of published cost-utility studies in child health
    Griebsch, I
    Brown, J
    VALUE IN HEALTH, 2004, 7 (06) : 640 - 640
  • [28] Health utilities used in oncology cost-utility analyses: a registry-based analysisHealth utilities in oncology CUAs
    Ting Zhou
    Zhiyuan Chen
    Brittany Humphries
    Feng Xie
    Quality of Life Research, 2025, 34 (3) : 801 - 807
  • [29] Age-Dependent Cost-Utility of Pediatric Cochlear Implantation
    Semenov, Yevgeniy R.
    Yeh, Susan T.
    Seshamani, Meena
    Wang, Nae-Yuh
    Tobey, Emily A.
    Eisenberg, Laurie S.
    Quittner, Alexandra L.
    Frick, Kevin D.
    Niparko, John K.
    EAR AND HEARING, 2013, 34 (04): : 402 - 412
  • [30] Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Lindarte, Erika Fernanda
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (08) : 967 - 973